MobiHealth News April 19, 2022
Also: RPM company Blue Spark Technologies brought in $40 million in IP-backed debt financing, and Click Therapeutics secured a $15 million loan.
Clinical trial tech company Unlearn scored $50 million in a Series B financing round led by Insight Partners.
Other participants in the round include Radical Ventures, 8VC, DCVC, DCVC Bio and Mubadala Capital Ventures. According to Crunchbase, Unlearn’s total raise now totals nearly $70 million.
Unlearn uses a machine learning model to create digital twins of randomized controlled trial participants. The startup pitches this tech as a way to run smaller clinical trials more quickly, since they don’t need to find as many participants for the control group.
“By reducing the size of the control arm,...
Today's Sponsors
Today's Sponsor